Familial chronic myeloproliferative disorders: the state of the art

Hematological Oncology
Elisa Rumi

Abstract

Familial chronic myeloproliferative disorders are defined when in the same pedigree at least two relatives have a chronic myeloproliferative disorder (CMD) as polycythemia vera (PV), essential thrombocythemia (ET) or primary myelofibrosis (PMF). This condition should be distinguished from inherited disorders with Mendelian transmission and single haematopoietic lineage proliferation, named hereditary erythrocytosis and thrombocytosis. The recently discovered mutations in patients with CMD (V617F and exon 12 of JAK2 gene, MPL gene), and those identified in hereditary erythrocytosis and in hereditary thrombocytosis have improved our ability to discriminate these conditions. In familial CMD, the JAK2 mutations are acquired and occur as secondary genetic events. As both mutations of the JAK2 gene have been reported in the same pedigree, a genetic predisposition to the acquisition of the JAK2 mutations is supposed to be inherited. The prevalence of familial cases within CMD is at least 7.6%. The inheritance pattern of familial CMD is consistent with an autosomal dominant trait with decreased penetrance. The clinical presentation at diagnosis of patients with familial CMD does not differ from that of patients with sporadic CMD. In ad...Continue Reading

References

May 1, 1976·Annals of Internal Medicine·M A LichtmanJ W Adamson
Nov 1, 1978·The Journal of Clinical Investigation·R RosaJ Rosa
Jan 1, 1981·American Journal of Hematology·M L FriedlandR J Robinson
Jan 1, 1981·American Journal of Hematology·R RosaJ Rosa
Jun 30, 1995·Science·Jaroslav F PrchalL Sokol
Jul 1, 1994·American Journal of Hematology·M Pérez-EncinasS Tome
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·A de la ChapelleE Juvonen
Feb 1, 1996·American Journal of Hematology·T InabaM Nakagawa
Feb 1, 1996·American Journal of Hematology·C DuhemM Dicato
Oct 1, 1996·Annals of Hematology·P C GiordanoL F Bernini
Dec 1, 1996·Melanoma Research·A M GoldsteinM A Tucker
Mar 6, 1998·British Journal of Haematology·M J PercyT C Pearson
Nov 21, 1998·Leukemia·M R YuilleD Catovsky
Dec 19, 1998·British Journal of Haematology·H A DeshpandeP H Wiernik
Apr 27, 2000·The New England Journal of Medicine·Ayalew Tefferi
Sep 9, 2000·The New England Journal of Medicine·J Benbassat
Sep 18, 2001·American Journal of Hematology·Robert Kralovics, Josef T Prchal
May 4, 2002·Blood Cells, Molecules & Diseases·Sonny O AngJosef T Prchal
Sep 20, 2002·Blood·James W VardimanRichard D Brunning
Nov 5, 2002·Nature Genetics·Sonny O AngJosef T Prchal
Jul 5, 2003·American Journal of Human Genetics·Yves PastoreJosef T Prchal
Jul 25, 2003·Biochemical and Biophysical Research Communications·Murat O ArcasoyZishan A Haroon
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
May 15, 2004·British Journal of Haematology·K B PetersenC Guldborg Nyvold
Jul 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Alison R MoliternoJerry L Spivak
Jul 30, 2004·American Journal of Hematology·Tohru FujiwaraTakeshi Sasaki
Nov 16, 2004·The American Journal of Medicine·Francesco PassamontiMario Lazzarino
Mar 23, 2005·Lancet·E Joanna BaxterCancer Genome Project
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek Skoda
Jun 15, 2005·Annual Review of Biochemistry·William G Kaelin
Jul 28, 2005·Cancer·Francesco PassamontiMario Lazzarino
Aug 5, 2005·Leukemia·Elisabetta AntonioliAlessandro M Vannucchi
Oct 4, 2005·British Journal of Haematology·Alexandra P WolanskyjAyalew Tefferi
Dec 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiaohui LuHarvey F Lodish
Jan 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Melanie J PercyFrank S Lee
Sep 26, 2006·British Journal of Haematology·N TecuceanuA Inbal
Feb 3, 2007·The New England Journal of Medicine·Linda M ScottAnthony R Green
Mar 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luciana TeofiliLuigi M Larocca
May 9, 2007·Hemoglobin·Ferdane Kutlar
Sep 14, 2007·Leukemia·C Bellanné-ChantelotFrench group on myeloproliferative disorders
Nov 14, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elisa RumiMario Lazzarino
Nov 21, 2007·Hematology·Radek Skoda
Jan 11, 2008·The New England Journal of Medicine·Melanie J PercyFrank S Lee

Citations

Oct 4, 2012·European Journal of Human Genetics : EJHG·K HusseinH Kreipe
Sep 6, 2014·Best Practice & Research. Clinical Haematology·Wan-Jen Hong, Jason Gotlib
Sep 10, 2014·Current Hematologic Malignancy Reports·Evan M Braunstein, Alison R Moliterno
Sep 27, 2012·Hematology/oncology Clinics of North America·Ashot S Harutyunyan, Robert Kralovics
Jul 24, 2012·Blood Cells, Molecules & Diseases·Sandra MalakFrench Group of Familial Myeloproliferative Disorders
Sep 17, 2009·British Journal of Haematology·Kari HemminkiJusto L Bermejo
Nov 14, 2008·American Journal of Hematology·Melanie J Percy, Elisa Rumi
Oct 26, 2012·Clinical Genetics·A RanjanOle Weis Bjerrum
Feb 10, 2011·British Journal of Haematology·Luciana Teofili, Luigi M Larocca
Mar 13, 2015·Current Treatment Options in Oncology·P H Wiernik
Mar 29, 2013·Blood·Adam J MeadSten Eirik W Jacobsen
Apr 27, 2017·British Journal of Haematology·Elisa Rumi, Mario Cazzola
May 3, 2018·Acta Haematologica·Michael Asger AndersenKaare Christensen
Apr 7, 2009·British Journal of Haematology·Sagar Lonial, Jamie Cavenagh
Jan 1, 2012·ISRN Molecular Biology·Jean-Jacques Lebrun

Related Concepts

JAK2 protein, human
Erythrocytosis
Polycythemia Vera
Thrombocytosis, Autosomal Dominant
Thrombocytosis
Janus kinase 2
Primary Myelofibrosis
Primary Myelofibrosis
Bone Marrow Hyperplasia
Complication

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Computational Methods for Protein Structures

Computational methods employing machine learning algorithms are powerful tools that can be used to predict the effect of mutations on protein structure. This is important in neurodegenerative disorders, where some mutations can cause the formation of toxic protein aggregations. This feed follows the latests insights into the relationships between mutation and protein structure leading to better understanding of disease.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.